Nasdaq Gets a Healthy Dose of Psychedelics With Lucy Scientific

February 17, 2023 · Yahoo!Finance

Lucy Scientific Discovery Inc. (Nasdaq: LSDI), which focuses on psychotropic drugs and had its initial public offering last week, rang the closing bell at the Nasdaq stock exchange today in New York.

The company is focused on becoming the premier research, development, and manufacturing organization for the emerging psychedelics-based medicines industry, it said in a statement.

“This milestone marks a significant step in the company’s growth and plans for expansion,” said CEO Chris McElvany. “We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”

Mind-bending psychedelics including MDMA (aka “ecstasy”), “magic mushrooms” and LSD are being studied as potential treatments for depression, post-traumatic stress disorder and addiction. Dozens of companies and academic laboratories are also making changes to the structure of those drugs, or designing similar compounds, to take advantage of their therapeutic properties without the high.

Psychedelic drugs including psilocybin and LSD could help patients grow new neural connections in the brain, some studies in animals and people suggest. The trip, together with therapy, likely help people shift their mind-set and process past experiences, changing their outlook and patterns of thinking.

The company’s Board is led by Executive Chairman Richard Nanula, a former Executive Vice President and CFO at the Walt Disney Co., as well as executive roles as the COO of Starwood Hotels, EVP of Finance and Strategy at Amgen.

Separately, Lucy Scientific filed an amendment to its current Dealer’s License with Health Canada to add cocaine and heroin.

The company said the expansion represents an effort to supply harm reduction programs globally. It criticized the “failed war on drugs” and said the company seeks to “reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States.”

The company already has licenses from Health Canada to make psilocybin, MDMA, LSD and mescaline. (Full Story)

In categories:Finance Psychedelics
Next Post

What’s it like to take a $249 drug-free psychedelic trip? We found out

I’m familiar with magic mushrooms from back in the day. I took them a couple times in college — including on a particularly memorable Halloween — and thoroughly enjoyed the experience. So I was curious about a Santa Monica-based startup…
Read
Previous Post

Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US

Israeli-based next-gen psychedelics biotech Clearmind Medicine  CMND+0.83%+ Free Alerts together with partner clinical-stage pharma company SciSparc SPRC-0.44%+ Free Alerts has filed three provisional patent applications with the United States Patent and Trademark Office (USPTO). The patents cover psychedelic-based therapeutics, including monotherapy and novel combinations…
Read
Random Post

Costa Rica issues first medical marijuana cultivation license

The government of Costa Rica issued the first business license to cultivate and process marijuana for medical purposes, according to local media reports. Costa Rica’s Ministry of Agriculture and Livestock (MAG) issued the license to Azul Wellness S.A., The Tico Times newspaper…
Read
Random Post

Washington Lawmakers Approve Bill To Allow Cross-Border Marijuana Sales

Legislation to eventually allow Washington State marijuana companies to engage in interstate commerce passed out of a House committee on Tuesday. A companion bill on the Senate side cleared its own committee hurdle last month. If the legislation is enacted, interstate…
Read
Random Post

Nobel Prize Winning Chemist Says Medical Cannabis Has Therapeutic Benefits and Is Real Medicine

Professor Aaron Ciechanover's captivating odyssey takes us from the confines of a research laboratory into the enigmatic realms of the cannabis industry. This prominent Nobel laureate in chemistry has recently deviated from his colleagues' well-worn route, immersing himself in the cannabis arena.…
Read
Random Post

Everything You Need to Know About Florida Weed Laws

While Florida legislators might not be in the Willie Nelson mindset some may hope, 2023 still looks more promising than any year before. Since Florida voters passed Amendment Two and legalized medicinal marijuana in 2016, ads for marijuana doctors are…
Read